Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes

Parkinson’s disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP) are characterized by nigrostriatal degeneration. We used [(18)F]FDG PET to assess glucose metabolism of the substantia nigra (SN) in patients with these diseases and evaluated its ability to discriminat...

Descripción completa

Detalles Bibliográficos
Autores principales: Schröter, Nils, Blazhenets, Ganna, Frings, Lars, Jost, Wolfgang H., Weiller, Cornelius, Rijntjes, Michel, Meyer, Philipp T., Brumberg, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519554/
https://www.ncbi.nlm.nih.gov/pubmed/36171206
http://dx.doi.org/10.1038/s41531-022-00392-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519554/
https://www.ncbi.nlm.nih.gov/pubmed/36171206
http://dx.doi.org/10.1038/s41531-022-00392-x

Ejemplares similares